Nelson Mullins Riley & Scarborough

Nelson Mullins Riley & Scarborough is a multistate firm with primary locations in the Southeast and Northeast regions of the United States. The firm currently holds rankings for its IP practices in South Carolina, North Carolina and Massachusetts.

Key practitioners employed by the firm are Mark Dukes, Susan Jackson, Craig Killen, Jane Remillard, Anthony Laurentano and Jill Gorny Sloper.

Over the past year, the firm has continued to assist client Bristol-Myers Squibb in patent prosecution and strategy, lately focusing on the company’s immunooncology program. The team is managing IP assets covering antibodies directed to new, high-profile targets for cancer therapy.

Other key clients in patent prosecution include SiOnyx, Navico Holdings, Acelity, Sonoco Products and Procella Therapeutics.

In the patent litigation arena, the firm was recently active for Korean biotech client Raphas at the ITC. Following discovery, the opponent that brought the complaint withdrew from the matter.

The firm was also active in patent disputes for FARO Technologies and Genome & Company.